JP2017500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500030A5
JP2017500030A5 JP2016538531A JP2016538531A JP2017500030A5 JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5 JP 2016538531 A JP2016538531 A JP 2016538531A JP 2016538531 A JP2016538531 A JP 2016538531A JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5
Authority
JP
Japan
Prior art keywords
acid sequence
seq
set forth
nucleic acid
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017500030A (ja
JP7078350B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2013/075137 external-priority patent/WO2014093894A2/en
Application filed filed Critical
Priority claimed from PCT/US2014/070188 external-priority patent/WO2015089492A2/en
Publication of JP2017500030A publication Critical patent/JP2017500030A/ja
Publication of JP2017500030A5 publication Critical patent/JP2017500030A5/ja
Priority to JP2021108614A priority Critical patent/JP2021166534A/ja
Application granted granted Critical
Publication of JP7078350B2 publication Critical patent/JP7078350B2/ja
Priority to JP2023108341A priority patent/JP2023138998A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538531A 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法 Expired - Fee Related JP7078350B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021108614A JP2021166534A (ja) 2013-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法
JP2023108341A JP2023138998A (ja) 2012-12-13 2023-06-30 Ｄｎａ抗体構築物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361896646P 2013-10-28 2013-10-28
PCT/US2013/075137 WO2014093894A2 (en) 2012-12-13 2013-12-13 Dna antibody constructs and method of using same
USPCT/US2013/075137 2013-12-13
PCT/US2014/070188 WO2015089492A2 (en) 2013-12-13 2014-12-13 Dna antibody constructs and method of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020035240A Division JP2020108381A (ja) 2012-12-13 2020-03-02 Ｄｎａ抗体構築物及びその使用方法
JP2021108614A Division JP2021166534A (ja) 2012-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法

Publications (3)

Publication Number Publication Date
JP2017500030A JP2017500030A (ja) 2017-01-05
JP2017500030A5 true JP2017500030A5 (https=) 2018-01-25
JP7078350B2 JP7078350B2 (ja) 2022-05-31

Family

ID=81845563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538531A Expired - Fee Related JP7078350B2 (ja) 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法

Country Status (1)

Country Link
JP (1) JP7078350B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014093894A2 (en) * 2012-12-13 2014-06-19 The Trustees Of The University Of Pennsylvania Dna antibody constructs and method of using same
GB201704417D0 (en) 2017-03-20 2017-05-03 Univ Copenhagen Improved li vaccine adjuvant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005017149A1 (en) 2003-06-03 2005-02-24 Cell Genesys, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7714119B2 (en) * 2004-07-13 2010-05-11 Biosante Pharmaceuticals, Inc. AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
CN108610416B (zh) 2008-10-13 2022-01-14 生物医学研究所 登革热病毒中和抗体及其用途

Similar Documents

Publication Publication Date Title
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
JP2016529229A5 (https=)
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
JP2016053091A5 (https=)
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
IL288541B (en) Vaccine against rsv
CR20230026A (es) Proteínas de fusión gdf15 y usos de estas (divisional 2018-0532)
JP2013107899A5 (https=)
AR107290A1 (es) ANTICUERPOS PEPTÍDICOS b AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
EA201491049A1 (ru) Противораковый слитый белок
EA201200515A1 (ru) Полипептиды и их применение
HRP20231496T1 (hr) Cistein proteaza
JP2015212284A5 (https=)
JP2016501535A5 (https=)
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
PE20211272A1 (es) POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO
BR112013029409A8 (pt) produtos farmacêuticos de peptídeo melhorados para resistência à insulina
BR112015020315A2 (pt) conjugação de anticorpo-fármaco sítio-específica por glicoengenharia
JP2017537621A5 (https=)
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
JP2016520534A5 (https=)